ASX to come under pressure as overseas stock markets lose momentum

Published 07-MAY-2020 09:02 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The Australian sharemarket faced headwinds on Thursday after finishing down 22 points or 0.4% on Wednesday.

There was a late sell-off in the US with the Dow trading in very similar fashion to the previous day.

The index shed around 200 points in the last hour of trading, partly triggered by disturbing data regarding the wiping of 20.2 million jobs in April. Some analysts are tipping that the unemployment rate could come in at around 15% as this continues to unfold.

President Donald Trump summed the situation up yesterday in his own inimitable style in saying ‘’it is a very bad subject’’ — the words of a true statesman.

Given this backdrop it isn’t surprising to see the SPI200 ASX futures down 48 points to 5348 points.

24 hours

In Asia, the Hang Seng was up 1.1% or 288 points to 24,137 points.

The Shanghai Composite rallied strongly late in the day to gained 0.6%, closing at 2878 points.

Similar to the Dow, the FTSE 100 endured a late session sell-off. It closed four points higher at 5803 points, but earlier in the day had pushed up towards the 5900 point mark.

The DAX and the CAC 40 were both off about 1.1% closing at 10,606 and 4433 points respectively.

The Dow started the day strongly, touching on 24,050 points before plummeting nearly 400 points to close at 23,664 points, a fall of 0.9%.

The S&P 500 was down 20 points to 2848 points.

The NASDAQ bucked the trend, gaining 45 points or 0.5% to close at 8854 points.

As markets unravelled, the CBOE Volatility Index gained traction, increasing from 32 points to 34 points during afternoon trading.

There was little support to be had on the commodities front with both gold and oil falling substantially, the former losing some of its previous day’s gains to close around the US$30.00 per barrel mark.

Gold fell 1.4% to US$1686 per ounce, its lowest close in a month.

The Australian dollar slipped below the US$0.64 mark for the first time in a fortnight.

On the base metals front, zinc surged overnight, and it is now close to the 60 day high of US$0.90 per pound.

There was also good support for nickel as it increased from US$5.40 per pound to US$5.52 per pound.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X